SCHEMBL571229

SCHEMBL571229

O=S(=O)(O)c1ccccc1C(Nc1ncncn1)=C(Nc1ncncn1)c1ccccc1S(=O)(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDX3X O00571 2/20 0.40
CA1 P00915 3/20 0.36
CA2 P00918 3/20 0.36
CA9 Q16790 2/20 0.36
NFKB1 P19838 1/20 0.35
SMAD3 P84022 1/20 0.35
CA5A P35218 1/20 0.35
TTR P02766 2/20 0.34
POLB P06746 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33
MMP8 P22894 1/20 0.33
MMP13 P45452 1/20 0.33
BCAT2 O15382 1/20 0.33
MYC P01106 1/20 0.33
CHRNB2 P17787 1/20 0.32
CHRNB4 P30926 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3809203 0.81 DDX3X (0.33) DDX3XTDP1
Sulfuric Acid SCHEMBL4728070 0.78 BCAT2 (0.39) CA1CA2CA9MEN1KMT2A
SCHEMBL11476196 0.75 TTR (0.39) CA1CA2CA9CA5ATTR
SCHEMBL7899594 0.75 CDK2 (0.42) CA1CA2CA9CA5ATTR
SCHEMBL3657587 0.74 TTR (0.48) CA1CA2CA9NFKB1TTR
SCHEMBL30398061 0.74 TTR (0.48) CA1CA2CA9NFKB1TTR
SCHEMBL27884994 0.73 DDX3X (0.46) DDX3XCA1CA2CA9POLB
SCHEMBL1072239 0.71 BCAT2 (0.40) POLBMEN1KMT2ABCAT2F2
SCHEMBL9766758 0.71 CA1 (0.51) CA1CA2CA9MMP1MMP2
SCHEMBL905677 0.71 RHOA (0.47) CA1CA2CA9TTRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013112511-A2 SEPARATED TREATMENT OF PAPER SUBSTRATE WITH MULTIVALENT METAL SALTS AND OBAS INTERNATIONAL PAPER COMPANY (US) 2013-08-01 WO claimed
EP-2043657-A2 USE OF STILBENE DERIVATIVES FOR TREATMENT AND PREVENTION OF AQUATIC MOLD INFECTIONS Hadasit Medical Research Services And Development Ltd. (IL) 2009-04-08 EP claimed
WO-2008001368-A2 USE OF STILBENE DERIVATIVES FOR TREATMENT AND PREVENTION OF AQUATIC MOLD INFECTIONS HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD. (IL) 2008-01-03 WO claimed
US-5891609-A Photographic color developer replenishing concentrates TREBLA CHEMICAL COMPANY (US) 1999-04-06 US claimed
US-RE30227-E Agent for brightening and removing greyness from textiles CIBA-GEIGY CORPORATION (US) 1980-03-11 US claimed
US-4008172-A Agent for brightening and removing greyness from textiles CIBA-GEIGY CORPORATION (US) 1977-02-15 US claimed
EP-3987114-A1 PAPER SUBSTRATES INCORPORATING COVERT MARKING PIGMENTS, AND PROCESSES FOR OBTAINING AND USING SAME International Paper Company (US) 2022-04-27 EP disclosed
WO-2020263789-A1 PAPER SUBSTRATES INCORPORATING COVERT MARKING PIGMENTS, AND PROCESSES FOR OBTAINING AND USING SAME INTERNATIONAL PAPER COMPANY (US) 2020-12-30 WO disclosed
WO-2012018746-A1 ADDITION OF ENDOTHERMIC FIRE RETARDANTS TO PROVIDE NEAR NEUTRAL PH PULP FIBER WEBS INTERNATIONAL PAPER COMPANY (US) 2012-02-09 WO disclosed
WO-2012018749-A1 FIRE RETARDANT TREATED FLUFF PULP WEB AND PROCESS FOR MAKING SAME INTERNATIONAL PAPER COMPANY (US) 2012-02-09 WO disclosed
EP-0682145-B1 Textile treatment CIBA SC HOLDING AG (CH) 2004-08-25 EP disclosed
US-5891609-A Photographic color developer replenishing concentrates TREBLA CHEMICAL COMPANY (US) 1999-04-06 US disclosed
EP-0404293-A2 Thickened acidic liquid composition with sulfonate FWA The Clorox Company (US) 1990-12-27 EP disclosed
US-RE30227-E Agent for brightening and removing greyness from textiles CIBA-GEIGY CORPORATION (US) 1980-03-11 US disclosed
US-4152152-A Additives for contrast control in organic photoconductor compositions and elements EASTMAN KODAK COMPANY (US) 1979-05-01 US disclosed
US-4008172-A Agent for brightening and removing greyness from textiles CIBA-GEIGY CORPORATION (US) 1977-02-15 US disclosed